In this episode, Professor Escudier from Gustave Roussy, a major cancer center in Paris France, discusses the advances in kidney cancer treatment over the past 30 years. Professor Escudier discusses the significance of the Keynote 564, the first positive trial in adjuvant renal cell cancer. He explains how these findings impact first-line treatment decisions for metastatic kidney cancer. He discusses the differences between cure, complete response and the role of the MDT, clinical and pathological biomarkers in treatment selection. Professor Escudier especially covers the questions that he patient should their doctors concerning their renal cancer and defines the differences between Clear Cell and Non-Clear Cell renal cancer treatment outcomes and expectations.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Monster: BTK
'Monster: BTK', the newest installment in the 'Monster' franchise, reveals the true story of the Wichita, Kansas serial killer who murdered at least 10 people between 1974 and 1991. Known by the moniker, BTK – Bind Torture Kill, his notoriety was bolstered by the taunting letters he sent to police, and the chilling phone calls he made to media outlets. BTK's identity was finally revealed in 2005 to the shock of his family, his community, and the world. He was the serial killer next door. From Tenderfoot TV & iHeartPodcasts, this is 'Monster: BTK'.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.